Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 11000-11011
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.11000
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.11000
Treatment group | Control group | |
Acupuncture points | Zusanli (ST36) | 20 mm away from the posterior of ST36 |
Shangjuxu (ST37) | 20 mm away from the posterior of ST37 | |
Gongsun (SP4) | On the medial aspect of the 1st cuneiform bone, between LR4 and SP4 | |
Sanyinjiao (SP6) | 15 mm away from the anterior of SP6, on the medial aspect of the tibia | |
Taixi (KI3) | 15 mm away from the anterior of KI3, on the medial aspect of the tibia | |
Taichong (LR3) | On the dorsal aspect of the 1st metatarsal bone between LR3 and SP3 | |
Moxibustion points | Tianshu (ST25), Qihai (CV6), Zhongwan (CV12) |
- Citation: Bao CH, Zhao JM, Liu HR, Lu Y, Zhu YF, Shi Y, Weng ZJ, Feng H, Guan X, Li J, Chen WF, Wu LY, Jin XM, Dou CZ, Wu HG. Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn’s disease. World J Gastroenterol 2014; 20(31): 11000-11011
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/11000.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.11000